| CTRI Number |
CTRI/2026/03/105544 [Registered on: 06/03/2026] Trial Registered Prospectively |
| Last Modified On: |
02/03/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Use of Boger Boenninghausen Characteristics and Repertory In Treating Cases Of Allergic Rhinitis |
|
Scientific Title of Study
|
Applicability Of BBCR Repertory in Cases Of Allergic Rhinitis. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Chauhan Dipesh Rajkishor |
| Designation |
PG Scholar |
| Affiliation |
C.D. Pachchigar College of Homoeopathic Medicine and Hospital. |
| Address |
Department Of Homoeopathic Repertory And Case Taking Division of MD Second Floor of C D Pachchigar college of homoeopathic Medicine And Hospital Near Navjivan Circle Udhana Magdalla Road Bhatar Surat.
Surat
GUJARAT
395001
India |
| Phone |
8160862495 |
| Fax |
|
| Email |
dipeshchauhan019@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Shrirang N Vyas |
| Designation |
Head of Department of Homoeopathic Repertory And Case Taking |
| Affiliation |
C.D. Pachchigar College of Homoeopathic Medicine and Hospital. |
| Address |
Department Of Homoeopathic Repertory And Case Taking Division of MD Second Floor of C D Pachchigar college of homoeopathic Medicine And Hospital Near Navjivan Circle Udhana Magdalla Road Bhatar Surat.
Surat
GUJARAT
395001
India |
| Phone |
9426185880 |
| Fax |
|
| Email |
drvyas@rediffmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Chauhan Dipesh Rajkishor |
| Designation |
PG Scholar |
| Affiliation |
C.D. Pachchigar College of Homoeopathic Medicine and Hospital. |
| Address |
Department Of Homoeopathic Repertory And Case Taking Division of MD Second Floor of C D Pachchigar college of homoeopathic Medicine And Hospital Near Navjivan Circle Udhana Magdalla Road Bhatar Surat.
Surat
GUJARAT
395001
India |
| Phone |
8160862495 |
| Fax |
|
| Email |
dipeshchauhan019@gmail.com |
|
|
Source of Monetary or Material Support
|
| C D Pachchigar College Of Homoeopathic Medicine And Hospital Near Navjivan Circle Udhana Magdalla Road Bhatar Surat 395001 Gujrat
|
|
|
Primary Sponsor
|
| Name |
C.D.Pachchigar Collage of Homoeopathic Medicine And Hospital |
| Address |
C D Pachchigar College Of Homoeopathic Medicine And Hospital Near Navjivan Circle Udhana Magdalla Road Bhatar Surat 395001 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Chauhan Dipesh Rajkishor |
C D Pachchigar college of Homoeopathic Medicine And Hospital. |
Department of Homoeopathic Repertory And CaseTaking Divison of MD 2ND FLOOR C D Pachchigar Collage Of Homoeopathic Medicine And Hospital Near Navjivan Circle Udhana Magdalla Road Bhatar Surat 395001
Surat
GUJARAT |
8160862495
dipeshchauhan019@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee Of C D Pachchigar College Of Homoeopathic Medicine And Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: J309||Allergic rhinitis, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Individualized Homoeopathic Medicine |
Potency Various such as Decimal Centesimal 50Millesimal etc Doses as per need of cases Medicines will be dispensed as per the potency Frequency as per need of cases Route of administration Oral Duration of therapy up to 9 months as per need of case |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
10.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Ability to comprehend and respond to symptoms rating scale (TNSS)
Age groups: between (10-60) years of age.
Gender: both male and female included |
|
| ExclusionCriteria |
| Details |
Patient on anti-allergic or steroids medication unwilling to discontinue.
Diagnosed cases of nasal polyp, deviated nasal septum or chronic
sinusitis and other severe co-morbidities associated with it.
Cases with irregular follow up of patients |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Change in Total Nasal Symptom Score (TNSS) from baseline to end of treatment. |
9 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Identification of most frequently prescribed remedies |
9 months |
|
|
Target Sample Size
|
Total Sample Size="30"
Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
13/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0"
Months="9"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
AIM : To evaluate the applicability of Boger Boenninghausen’s Characteristics Repertory (BBCR) in the management of cases of allergic rhinitisPRIMARY OBJECTIVE: To demonstrate the applicability of BBCR Repertory in cases of allergic rhinitis. SECONDARY OBJECTIVE: To identify the most commonly prescribed remedies for allergic rhinitis cases using the BBCR repertory. HYPOTHESIS: Null hypothesis (H0): There is no significant applicability of BBCR repertory in cases of Allergic Rhinitis. Alternative hypothesis (H1): There is significant applicability of BBCR repertory in cases of Allergic Rhinitis.
DATA MANAGEMENT AND OUTCOME MEASURMENT This study will be conducted as a prospective clinical study at the OPD and peripheral centers of C. D. Pachchigar Homoeopathic Medical College and Hospital, Surat. fulfilling the inclusion and exclusion criteria will be selected by simple random sampling after obtaining written informed consent.Patients aged between 10 to 60 years, of either gender, who are able to comprehend and respond to the Total Nasal Symptom Score (TNSS) scale will be included in the study. Patients who are unwilling to discontinue anti-allergic or steroid medications, diagnosed cases of nasal polyp, deviated nasal septum, chronic sinusitis, severe co-morbidities, or those with irregular follow-up will be excluded from the study . After detailed case taking as per Aphorisms 83–104 of Organon of Medicine and thorough physical examination, baseline clinical findings will be recorded in the structured case proforma. The severity of allergic rhinitis will be assessed using the Total Nasal Symptom Score (TNSS) Repertorization will be carried out using Boger Boenninghausen’s Characteristics Repertory (BBCR), and individualized homoeopathic medicine will be prescribed based on totality of symptoms (location, sensation, modalities, and concomitants). Follow-up assessments will be conducted at intervals of 3, 7, or 15 days depending on case requirement. At each follow-up visit, TNSS score will be reassessed and documented. Any changes in symptoms and remedy response will be recorded. outcome of the study will be change in Total Nasal Symptom Score (TNSS) from baseline to the end of treatment. TNSS will be calculated at baseline and during each follow-up visit to assess reduction in symptom severity |